Showing results (451-460 of 604) with videos related to

Sort By:
Pageof 61
Arthritis and Rheumatism|May 30, 2009
The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in FranceEric Hachulla, Pascal de Groote, Virginie Gressin, et al.
The New England Journal of Medicine|October 24, 2024
CRISPR-Based Therapy for Hereditary AngioedemaDanny M Cohn, Padmalal Gurugama, Markus Magerl, et al.
Plos One|May 30, 2013
Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohortJacques-Eric Gottenberg, Raphaèle Seror, Corinne Miceli-Richard, et al.
Arthritis and Rheumatism|April 11, 2012
Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunityEugénie Koumakis, Matthieu Giraud, Philippe Dieudé, et al.
Rheumatology (Oxford, England)|April 11, 2018
S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndromeLin Wang, Carlos D Rosé, Kevin P Foley, et al.
RMD Open|May 21, 2024
Severe enterovirus infections in patients with immune-mediated inflammatory diseases receiving anti-CD20 monoclonal antibodiesGrégoire Martin de Frémont, Hélène Chabrolles, Audrey Mirand, et al.
International Journal of Cardiology|August 28, 2017
Incidence, risk factors, and mortality of neonatal and late-onset dilated cardiomyopathy associated with cardiac neonatal lupusNathalie Morel, Kateri Lévesque, Alice Maltret, et al.
Autoimmunity Reviews|August 19, 2015
Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndromeKateri Levesque, Nathalie Morel, Alice Maltret, et al.
Annals of the Rheumatic Diseases|May 15, 2023
Points to consider: EULAR-UEMS standards for the training of European rheumatologistsAlessia Alunno, Tadej Avcin, Catherine Haines, et al.
The Lancet. Rheumatology|March 29, 2025
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?Marc Scherlinger, Gaetane Nocturne, Marko Radic, et al.
Pageof 61